Publication alert 🚨 This study, led by our fellow Dr. Mughrabi, describes the clinical outcomes of letermovir use as primary and secondary prophylaxis against cytomegalovirus in non-kidney solid organ transplant recipients. doi.org/10.1111/ctr.70473
Congratulations to the team!
Depletional induction = risk of BK recurrence; non-depletional induction = risk of rejection. Long-term outcome: similar! Great work led by Dr. Riad @SamyRiad9
Risk Factors and Outcomes of Pneumocystis jirovecii pneumonia in Kidney Transplant Recipients: A Case-Control Study of the United States Renal Data System - American Journal of Transplantation amjtransplant.org/article/S1…
Congratulations @MariAleMendozaD@dfrieds89@pascalisID
Fellows expressing gratitude to our amazing Program Director @RazonableMD who will be rotating out of his role. Thank you for your leadership, advocacy and support for fellow education!
Fellows expressing gratitude to our amazing Program Director @RazonableMD who will be rotating out of his role. Thank you for your leadership, advocacy and support for fellow education!
Our fantastic senior infectious disease fellow @MKerkelis presenting her work on parainfluenza infections in solid organ transplant recipients at the World Transplant Conference 2025. Great work supported by mentors @RazonableMD@nischalR3
Neurological disease is the most frequent syndrome of post-transplant HHV-6. Early recognition of limbic involvement through triad of confusion, amnesia and seizures or compatible MRI findings may help with early diagnosis. The sequelae can be disabling.
frontiersin.org/articles/10.…